uniQure N.V. Ordinary Shares vs STMicroelectronics NV — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while STMicroelectronics NV trades at $44.75 (market cap $43.80B). The key difference: STMicroelectronics NV is far larger — about 29.6× uniQure N.V. Ordinary Shares's market cap, and STMicroelectronics NV pays a 0.73% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and STMicroelectronics NV for 65 Days on average.
| QURE | STM | |
|---|---|---|
Market Cap | $1.48B | $43.80B |
Volume | 2,488,780 | 7,353,071 |
Sector | Health | Technology |
52-Week High | $70.59 | $79.91 |
52-Week Low | $9.03 | $21.20 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $728.62M | $41.32B |
Dividend Yield | — | 0.73% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
STM is trading at $46.9, down 7.09% in the last session, with a bearish technical signal. The company shows mixed fundamentals with a high P/E ratio of 94.59 but negative net income margin of -0.39%. Recent Q2 2026 earnings beat expectations with EPS of $0.31 versus $0.26 expected, while Q1 and Q4 2025 missed. Strong cash flow of $555M in 2025 and improving 2026 projections provide some optimism amid current weakness.
The outlook remains cautious with analyst consensus price target of $77.31 suggesting 65% upside potential. Key opportunities include AI data-center revenue projected to exceed $2B in 2027 and automotive sensor innovations. Risks include declining revenue trends from $17.3B in 2023 to $11.8B in 2025 and negative profitability metrics requiring careful monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →